Skip to main content

Advertisement

SpringerLink
Log in

Preoperative serum oxidative stress marker as a strong indicator of nodal involvement in clinical stage I lung adenocarcinoma

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Reactive oxygen species stimulate lymphatic metastasis by accelerating epithelial-to-mesenchymal transition and lymphangiogenesis in the tumor microenvironment. Hence, systemic oxidative stress level may correlate with nodal involvement in patients with a malignant tumor.

Methods

We examined 46 patients with clinical stage I lung adenocarcinoma who had undergone pulmonary resection with mediastinal lymph node dissection. Serum reactive oxygen metabolite (ROM) level was measured as an indicator of systemic oxidative stress. We investigated the association between nodal involvement and clinicopathological factors.

Results

Preoperative serum carcinoembryonic antigen (CEA; P = 0.045), cytokeratin 19 fragment (CYFRA21–1; P = 0.038), and ROM (P = 0.007) levels were significantly higher in patients with nodal involvement than in those without nodal involvement. A receiver operating characteristic curve was constructed to determine whether patients with and without nodal involvement could be differentiated on the basis of their serum ROM levels. The area under curve was 0.763 and the prognostic cut-off value was set at 318 Carratelli units. In univariate analysis, clinical stage IB (odds ratio [OR] = 4.55; P = 0.033), CEA-positive (OR = 5.56, P = 0.018), and ROM-positive (OR = 10.46, P = 0.006) were significant predictive factors for nodal involvement. In multivariate analysis, ROM-positive was an independent predictive factor for nodal involvement (OR = 6.22, P = 0.045).

Conclusion

Preoperative serum ROM level was an independent significant predictive factor for nodal involvement in patients with clinical stage I lung adenocarcinoma. Hence, serum ROM level may be a useful biomarker for staging of lung adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Tse JC, Kalluri R (2007) Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101:816–829

    Article  PubMed  CAS  Google Scholar 

  2. Rouzaut A, Irigoyen M, Montuenga LM (2007) Lymphangiogenesis and lung cancer. J Thorac Oncol 2:384–386

    Article  PubMed  Google Scholar 

  3. Christiansen JJ, Rajasekaran AK (2006) Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66:8319–8326

    Article  PubMed  CAS  Google Scholar 

  4. Radisky DC, Levy DD, Littlepage LE et al (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436:123–127

    Article  PubMed  CAS  Google Scholar 

  5. Achen MG, Stacker SA (2008) Molecular control of lymphatic metastasis. Ann NY Acad Sci 1131:225–234

    Article  PubMed  CAS  Google Scholar 

  6. Gencer M, Ceylan E, Aksoy N et al (2006) Association of serum reactive oxygen metabolite levels with different histopathological types of lung cancer. Respiration 73:520–524

    Article  PubMed  CAS  Google Scholar 

  7. World Health Organization (1999) Histological typing of lung and pleural tumors, 3rd edn edn. World Health Organization, Geneva

    Google Scholar 

  8. Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717

    Article  PubMed  CAS  Google Scholar 

  9. Naruke T, Suemasu K, Ishikawa S (1976) Surgical treatment for lung cancer with metastasis to mediastinal lymph nodes. J Thorac Cardiovasc Surg 71:279–285

    PubMed  CAS  Google Scholar 

  10. Yanbaeva DG, Dentener MA, Creutzberg EC et al (2007) Systemic effects of smoking. Chest 131:1557–1566

    Article  PubMed  CAS  Google Scholar 

  11. West IC (2000) Radicals and oxidative stress in diabetes. Diabet Med 17:171–180

    Article  PubMed  CAS  Google Scholar 

  12. Inoue T, Hayashi M, Takayanagi K et al (2003) Oxidative DNA damage is induced by chronic cigarette smoking, but repaired by abstention. J Health Sci 49:217–220

    Article  CAS  Google Scholar 

  13. Trotti R, Carratelli M, Barbieri M (2002) Performance and clinical application of a new, fast method for the detection of hydroperoxides in serum. Panminerva Med 44:37–40

    PubMed  CAS  Google Scholar 

  14. Poli G, Leonarduzzi G, Biasi F et al (2004) Oxidative stress and cell signalling. Curr Med Chem 11:1163–1182

    PubMed  CAS  Google Scholar 

  15. Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51:794–798

    PubMed  CAS  Google Scholar 

  16. Weissmann G, Smolen JE, Korchak HM (1980) Release of inflammatory mediators from stimulated neutrophils. N Engl J Med 303:27–34

    Article  PubMed  CAS  Google Scholar 

  17. Nishikawa M (2008) Reactive oxygen species in tumor metastasis. Cancer Lett 266:53–59

    Article  PubMed  CAS  Google Scholar 

  18. Mantovani G, Macciò A, Madeddu C et al (2002) Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. Int J Cancer 98:84–91

    Article  PubMed  CAS  Google Scholar 

  19. Mantovani G, Macciò A, Lai P et al (1998) Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Semin Oncol 25:45–52

    PubMed  CAS  Google Scholar 

  20. Sakao Y, Tomimitsu S, Takeda Y et al (2004) Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg 254:520–522

    Article  Google Scholar 

  21. Kamiyoshihara M, Kawashima O, Otani Y et al (2002) Clinical significance of the preoperative serum-soluble intercellular adhesion molecule-1 in non-small cell lung cancer. J Cardiovasc Surg 43:729–734

    CAS  Google Scholar 

  22. Tamura M, Oda M, Matsumoto I et al (2004) The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer. Ann Surg Oncol 11:928–933

    Article  PubMed  Google Scholar 

  23. Tamura M, Ohta Y (2003) Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis. Cancer 98:1217–1222

    Article  PubMed  CAS  Google Scholar 

  24. Tamura M, Oda M, Tsunezuka Y et al (2004) Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest 126:342–346

    Article  PubMed  CAS  Google Scholar 

  25. Sasaki H, Yukiue H, Mizuno K et al (2003) Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer. Int J Clin Oncol 8:79–82

    Article  PubMed  CAS  Google Scholar 

  26. Crohns M, Saarelainen S, Kankaanranta H et al (2009) Local and systemic oxidant/antioxidant status before and during lung cancer radiotherapy. Free Radic Res 43:646–657

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Ms. K. Yamada, Osaka City University Medical School, for her excellent technical assistance.

Conflict of interest

The authors have no relevant financial or other potential conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, Osaka City University Medical School Hospital, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan

    Takuma Tsukioka, Noritoshi Nishiyama, Takashi Iwata, Koshi Nagano, Keiko Tei & Shigefumi Suehiro

Authors
  1. Takuma Tsukioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noritoshi Nishiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takashi Iwata
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Koshi Nagano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keiko Tei
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shigefumi Suehiro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takuma Tsukioka.

About this article

Cite this article

Tsukioka, T., Nishiyama, N., Iwata, T. et al. Preoperative serum oxidative stress marker as a strong indicator of nodal involvement in clinical stage I lung adenocarcinoma. Int J Clin Oncol 17, 250–255 (2012). https://doi.org/10.1007/s10147-011-0283-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-011-0283-6

Keywords

Search

Navigation